Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer

IMPORTANCE: A critical decision in the management of metastatic castration-resistant prostate cancer (mCRPC) is when to administer an androgen receptor signaling (ARS) inhibitor or a taxane. OBJECTIVE: To determine if pretherapy nuclear androgen-receptor splice variant 7 (AR-V7) protein expression a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Scher, Howard I., Lu, David, Schreiber, Nicole A., Louw, Jessica, Graf, Ryon P., Vargas, Hebert A., Johnson, Ann, Jendrisak, Adam, Bambury, Richard, Danila, Daniel, McLaughlin, Brigit, Wahl, Justin, Greene, Stephanie B., Heller, Glenn, Marrinucci, Dena, Fleisher, Martin, Dittamore, Ryan
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5206761/
https://ncbi.nlm.nih.gov/pubmed/27262168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.1828
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars